Lipid abnormalities in streptozotocin-diabetes: Amelioration by morus indica L. cv Suguna leaves

International Journal of Diabetes in Developing Countries

Volumn 29, Issue 3, 2009, Pages 123-128

  Andallu, B ^a   Vinay Kumar, A ^b   Varadacharyulu, N ^c  

^a SRI SATHYA SAI INSTITUTE OF HIGHER LEARNING   (India)

^b TEXAS TECH UNIVERSITY   (United States)

^c SRI KRISHNADEVARAYA UNIVERSITY   (India)

Author keywords

Atherogenic index; Bile acids; Cholesterol; Hyperlipidemia; Mulberry leaves; STZ diabetic rats; Triglycerides

Indexed keywords

EID: 70349210434     PISSN: 09733930     EISSN: 19983832     Source Type: Journal    
DOI: 10.4103/0973-3930.54289     Document Type: Article

References (55)

1. Pyorala K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diab Metab Rev 1987;3:463-524.
2. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoeb lP, et al. Enhanced serum levels of thiobarbituric acid reactive substances in diabetes mellitus. The Am J Med 1995;98:469-475
3. Grant RW, Cagliero E, Murphy-Sheehy P, Singer DE, Nathan DM, Meigs JB. Comparison of hyperglycemia, hypertension and hypercholesterolemia management in patients with type 2 diabetes. The Am J Med 2002;112:603-609
4. Bhavapriya V, Kalpana S, Govindasamy S, Apparanantham T. Biochemical studies on hypoglycemic eff ect of Aavirai kudineer: A Herbal formulation in alloxan diabetic rats. Indian J Exp Biol 2001;39:925-928
5. Gale EA. Lessons from the triglitazones: A story of drug development. Lancet 2001;357:1870-1875
6. Padh HBV. Herbal drugs. Curr Sci 2001;81:15.
7. Hagura R. Diabetes mellitus and life-style-for the primary prevention of diabetes mellitus: The role of diet. Br J Nutr 2000;84:S191-4.
8. Sastri BN. In: The wealth of India, Raw materials. CSIR, New Delhi, India,1962;6: 429.
9. Li SZ. Compendium of Materia Medica. People.s Medical Publishing House, Be? ing, 1978; 2027.
10. Chen F, Nakashima N, Kimura I, Kimura M, Asano N, Koya S. Potentiating eff ects on pilocarpine induced saliva secretion by extracts and N-containing sugars derived from mulberry leaves in streptozotocin.diabetic mice. Biol Pharmacol Bull 1995;18:1676-1680
11. Chen F, Nakashima N, Kimura I, Kimura M. Hypoglycemic activity and mechanism of extracts from mulberry leaves (Folium Mori) and cortex mori radicis in streptozotocin- induced diabetic mice. Yakugaku Zasshi 1995;115:476.82.
12. Kimura M, Chen F, Nakashima N, Kimura I, Asano N, Koya S. Antihyperglycemic eff ects of N-containing sugars derived from mulberry leaves in streptozotocin .induced diabetic mice. J Tradnl Med 1995;12:214-219
13. Doi K, Kojima T, Makino M, Kimura Y, Fujimoto Y. Studies on the constituents of the leaves of Morus alba L. Chem Pharmacol Bull 2001;49:151-153
14. Rakieten N, Rakieten ML, Nadkarni V. Studies on the diabetic action of streptozotocin. Cancer Chemother Rep 1963;29:91-98
15. Trinder P. Determination of glucose by glucose oxidase method. Ann Clin Biochem 1969;6:24-26
16. Zlatkis A, Zak B, Boyle GJ. A direct method for the estimation of serum cholesterol. J Lab Clin Med 1953;41:486-488
17. Fossati P, Principe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem 1982;28:2077-2080
18. Connerty HV, Briggs AR, Eaton EH Jr. Simplifi ed determination of the lipid components of blood serum. Clin Chem 1961;7:589-590
19. Assmann G, Schriewer H, Schmitz G, Hagele EO. Quantification of high density lipoprotein cholesterol by precipitation with phosphotungstic acid-MgCl2. Clin Chem 1983;29:2026-2030
20. Itaya K, Ui M. Colorimetric determination of free fatt y acids in biological fluids. J Lipid Res 1965;6:16-20.
21. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
22. Kumari K, Mathew BC, Augusti KT. Antidiabetic and hypolipidemic eff ects of S-methyl cysteine sulfoxide isolated from Allium cepa Linn. Indian J Biochem Biophys 1995;32:49-54.
23. Scott LD. A new colorimetric method for the determination of biliary acids in body fluids, with a note in their alleged presence in normal blood. J Lab Clin Med 1934;19:523-528
24. Gupta SP. Stastical Methods. Sultan Chand and Sons, New Delhi,1995; 3.36 - 5.5.
25. Duncan DB. Multiple range and multiple F tests. Biometrics 1955;11:1-42.
26. Shew WH, Jeng CY, Lee WJ, Lin SY, Pei D, Chen YT. Simvastatin treatment in postprandial hypertriglyceridemia in type 2 diabetes mellitus patients with combined hyperlipidemia. Metab 2001;50:355-359
27. Bagdade JD, Helve E, Taskinen MR. Effect of continuous insulin infusion therapy lipoprotein surface and corelipid composition in IDDM. Metab 1991;40:445-449
28. Bett eridge DJ. Diabetes, lipoprotein metabolism and atherosclerosis. Br Med Bull 1989;45:285-311.
29. Taskinen MR, Bett z WF, Harper I. Effects of non insulin dependent diabetes mellitus on VLDL triglyceride and apolipoprotein B metabolism: studies before and aft er sulfonylurea therapy. Diabetes 1986;35:1268-1277
30. Arora P, Jain B, Kohli GK, Sehgal M, Goyal RK. Dyslipidemia in type 2 diabetes mellitus. Indian Medical Gazett e 2002;:258-260
31. Hollenbek CB, Chen YDI, Greenfi eld MS, Lardinois CK, Reaven GM. Reduced plasma high density lipoprotein cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in non insulin dependent diabetes mellitus. J Clin Endocrinol Metab 1986;62:605-608
32. Vantol A. Hypertriglyceridemia in diabetic rat, defective removal of serum VLDL. Atherosclerosis 1977;26:117-128
33. Babu PS, and Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rat. Mol Cell Biochem 1997;166:169-175
34. Howard BV. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-623
35. Castelli WP, Garrison RJ, and Wilson PWF. Incident of coronary heart disease and lipoprotein cholesterol levels: The Framingham study. J Am Med Assn 1986;256:2835-2838
36. Ferrett i G, Rabini RA, Bacchett i T, Vignini A, Salvolini E, Ravaglia F, Curatola G, and Mazzanti L, Glycated low density lipoproteins modify platelet properties: A compositional and functional study. Clin Endocrinol Metab 2002;87:2180-2184
37. Lyons TJ. Lipoprotein glycation and its metabolic consequences. Diabetes 1992;41:67-73.
38. Taylor R, Agius L. The biochemistry of diabetes. Biochem J 1988;250:625-640
39. Gordon T, Castelli WP, Hjortland MC. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 1997;62:707-714
40. Witztum JI, Fisher M, Pietro T, Steintracher UP, and Iiam RI. Nonenzymatic glucosylation of high density lipoprotein accelerates its catabolism in guinea pigs. Diabetes 1982;31:1029-1032
41. Nikkila EA, Huttunen JK, Ehnholin C. Post-heparin plasma lipoprotein lipase: Relationship to plasma triglycerides metabolism. Diabetes 1977;26:11-12
42. Norman L, Dutt a P, Lia A, Anderson H. Soy sterol esters andsitostanol ester as inhibitor of cholesterol absorption in human small bowel. Am J Clin Nutr 2000;71: 908-913
43. Furhman B, Buch S, Vaya J, Belinky PA, Loleman R, Hayek J. Aviram. Liocrice extract and its major polyphenol glabridin protect low density lipoprotein against lipid peroxidation; in vitro and in vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 1977;66:267-275
44. Robak J, Gryslenski RJ. Flavonoids are scavengers of superoxide anion. Biochem Pharmacol 1988;37:83-88
45. Khokhar S, Chauhan BM. Saponins in food-their physiological and nutritional signifi cance. Sci Culture 1985;52:287-291
46. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol lowering eff ects of dietary fi ber: A meta-analysis. Am J Clin Nutr 1999;69:30-43.
47. Salil G, Rajamohan T. Hypolipidemic and antiperoxidatice eff ect of coconut protein in hypercholesterolemic rats. Indian J Exp Biol 2001;39:1028-1034
48. Srinivasan K, Sambaiah K. The eff ect of spices on cholesterol 7-@ hydroxylase activity and on serum and hepatic cholesterol levels in the rat. Int J Vit Nutr Res 1991;61:364-369
49. Venkataeswaran S, Par L, Saravanan G. Eff ect of Phaseolus vulgaris on circulatory antioxidants and lipids in rats with streptozotocin. induced diabetes. J Med Food 2002;5:97-103.
50. Krinsky NI. Antioxidant functions of carotenoids. Free Rad Biol Med 1989;7:617-635
51. Shafi ee M, Carbonneau M, D.Huart J, Desscomp B, Leger CL. Synergistic antioxidative properties of phenolics from natural origin towards low density lipoproteins depend on the oxidative system. J Med Food 2000;5:69-77.
52. Beacher GR. .Phytonutrients. role in metabolism:Effects on resistance to degenerative processes. Nutr Rev 1999;57:S3.6.
53. Upritchard JE, Sutherland WH, Mann JL. Effect of supplementation with tomato juice, vitamins E and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diab Care 2000;23:733-736
54. Levy Y, Zaltsberg H, Ben Amotz A, Kanter Y, Aviram M. Dietary supplement of a natural isomer mixture of beta-carotene inhibits oxidation of LDL derived from patients with diabetes mellitus. Ann Nutr Metab 2000;44:54-60.
55. Doi K, Kojima T, Fujimoto Y. Mulberry leaf extract inhibits oxidative modifi cation of rabbit and human low density lipoprotein. Biol Pharmacol Bull 2000;23:1066-1071